CompletedPhase 2NCT00295854
Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Studying Interstitial cystitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- MediciNova
- Principal Investigator
- Richard E Gammans, MDMediciNova, Inc.
- Intervention
- MN-001 BID(drug)
- Enrollment
- 296 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2005 – 2006
Study locations (28)
- MediciNova Investigational Site, Birmingham, Alabama, United States
- Citrus Valley Urological Medical Group, Glendora, California, United States
- Atlantic Urological Medical Group, Long Beach, California, United States
- Mendez Transplant and Urological Medical Group, San Diego, California, United States
- Boulder Medical Center, P.C., Boulder, Colorado, United States
- Western Urologic Research Center, Wheat Ridge, Colorado, United States
- Segal Institute for Clinical Research, Aventura, Florida, United States
- Visions Clinical Research, Boynton Beach, Florida, United States
- West Florida Urology, Palm Harbor, Florida, United States
- Adult and Pediatric Urology, Plantation, Florida, United States
- Georgis Patsias, MD., PA, Wellington, Florida, United States
- Shepherd Center, Inc., Atlanta, Georgia, United States
- Center For Advanced Pelvic Surgery, Centralia, Illinois, United States
- Evanston Continence Center, Evanston, Illinois, United States
- Regional Urology, LLC, Shreveport, Louisiana, United States
- +13 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00295854 on ClinicalTrials.govOther trials for Interstitial cystitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT06752603A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial CystitisOno Pharmaceutical Co. Ltd
- RECRUITINGEARLY PHASE1NCT04734106Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial CystitisWake Forest University Health Sciences
- RECRUITINGNANCT06366269Acupuncture First for IC/BPSUniversity Hospitals Cleveland Medical Center
- RECRUITINGPHASE2NCT06394830Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)Vaneltix Pharma, Inc.
- RECRUITINGNCT06729151Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain SyndromeWalter Reed National Military Medical Center
- RECRUITINGNCT06719232Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical InstillationJahn Ferenc South Pest Teaching Hospital
- RECRUITINGPHASE2, PHASE3NCT06096597Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder SyndromeDavid Sheyn
- RECRUITINGNANCT06299683Pain Type and Interstitial Cystitis/Bladder Pain Syndrome TreatmentVanderbilt University Medical Center